This panel uses Immunosciences Lab's patented ELISA methodology, as well as the Western Blot technique, to measure 26 different antibodies against Lyme-specific antigens, Borrelia subspecies, and co-infections. It can detect active and chronic Lyme disease, including Lyme arthritis and neuroborreliosis that may be confused with multiple sclerosis.
This is a comprehensive test panel for detecting active and chronic Lyme disease, which may result in Lyme arthritis and neuroborreliosis. It measures antibodies against the spirochete and various components of B. Burgdorferi, its subspecies, and co-infections.
ISL uses both Borrelia antigens grown in culture and the various proteins expressed in vivo, enabling us to improve the accuracy of our determinations.
In this panel, we use both our own patented ELISA methodology (tier one) as well as the Western Blot method (tier two) to measure IgG and IgM antibodies not only against a mixture of Borrelia antigens but
also against proteins or peptides of different molecular sizes, such as Outer Surface Protein A (OspA), Outer Surface Protein B (OspB), Outer Surface Protein C (OspC), Outer Surface Protein E (OspE), Leukocyte Function Associated Antigen (LFA), Variable Major Protein (VMP), and more, each component determined separately. We also measure antibodies against antigens known for their involvement with Lyme disease, including antibodies against the Borrelia subspecies Sensu stricto, Afzelii, Garinii, and Myamotoi, as well as the co-infections Babesia, Ehrlichia, and Bartonella.
It is vital to correctly determine as early as possible whether someone is developing Lyme disease or something else. False positive test results could lead to years of incorrect treatment and unnecessary medications with their side effects, while false negative results could lead to Lyme arthritis, neuroborreliosis, and years or even a lifetime of suffering.
These false positive or false negative results may be avoided by running the Western Blot, which is included in Immunoserology of Lyme Disease Panel B.
This panel is beneficial for a wide variety of patients with the following:
The Immunoserology of Lyme Disease Panel B should be considered when patients present the following symptoms and conditions, which are represented in the figure below:
Lyme borreliosis in humans is an inflammatory disease affecting multiple organ systems, including the nervous system, cardiovascular system, joints, and muscles.
This panel uses Immunosciences Lab's patented ELISA methodology, as well as the Western Blot technique, to measure 26 different antibodies against Lyme-specific antigens, Borrelia subspecies, and co-infections. It can detect active and chronic Lyme disease, including Lyme arthritis and neuroborreliosis that may be confused with multiple sclerosis.
Hey Practitioners! Want to learn from New York Times best-selling author Dr. Casey Means? In this upcoming free live class for practitioners, Dr. Means will teach us about the clinical importance of understanding metabolic health in every patient, how to test for it, and key dietary and lifestyle changes that can start to improve it. Sign up here!